Skip to content
Search

Latest Stories

Lo’s Pharmacy frees up 4 hrs daily for pharmacists with hub and spoke model

Lo’s Pharmacy frees up 4 hrs daily for pharmacists with hub and spoke model

The hub and spoke model of dispensing is a crucial resource to help pharmacies cope with an ever-increasing workload

Just over a year ago, Lo’s Pharmacy Group went live with a hub and spoke model of dispensing for their original pack repeat prescriptions. Since then, the group has freed up an average of four hours per day for their pharmacists working in branch.

In this article, brothers Chris and Jonathan Lo speak about why they chose hub and spoke and the impact it has had on their business.


“Our pharmacy teams have been working at 110 per cent for a prolonged period of time. Despite this, we realised that the government was only going to shift more and more work onto community pharmacies and so we needed to build the capacity for this extra work. We decided to do this by transferring most of our original pack dispensing workload to our central hub,” explains Chris.

The family-owned group, which has 39 pharmacies primarily in Yorkshire, invested in Centred Solutions FLOWRx Hub solution, pharmacy robotic technology that labels, sorts, bags and totes original packs for patient prescriptions. They also rolled out FLOWRx InStore to their branches. This software connects pharmacy branches to the pharmacy hub and allows stores to receive bagged medications efficiently with the ability to top up, if needed, in store.

“The hub went live with our first pharmacy in February 2023 and then we acquired 12 new pharmacies during March and April of that year so we had two gigantic projects clash at the same time. As with any new technology, there was a learning curve but the software is a great end-to-end solution that does exactly what we need.

“The most difficult part was the culture change and the overhaul of the dispensing process. We were all learning at the time, and in many respects, we still are,” says Chris.

How the hub and spoke model works

The hub employs one pharmacist and 10 support staff, including an ACT. The team does everything from goods-in to producing the final hub tote. Patient orders are clinically and accurately checked online by the pharmacist in-store and are then sent to the hub where the team “batch pick” medication from shelf locations in the hub.

“The whole stock situation remains volatile, but we currently hold around 750 medication lines at the hub and we plan to increase this. Staff at the hub manually pick medication to fulfill orders.

“On average a 200-pack pick takes around 10 minutes. Our hub is set up as a one-way route so we can start the pick at location 1 and then follow the path all the way to location 65. It’s set up so there is no going back on yourself to ensure the picking process is efficient,” explains Jonathan.

Once the packs are picked the medication is then labelled on either the automated hub line or the manual hub line before it is sorted and then bagged and placed in a tote ready for delivery back to the store.

“The difference between the automated line and the manual line is the Automated Labelling Unit (ALU). The majority of our volume goes through the ALU, which is about five times faster than the manual line. On the manual line, an operator physically scans each pack and then attaches each label. We deploy the manual line during peak periods to give us extra capacity,” says Jonathan.

The hub services 30 of the group’s branches and it processed 203,000 packs in January this year which equates to around 140,000 items.

“We definitely have the capacity to do more, it’s a continuous journey to improving processes and getting the best out of the system. As our company grows, so will our hub process,” says Jonathan.

The brothers say their pharmacy teams were nervous at first, but have now realised that a hub and spoke model means a quicker turnaround time in terms of them receiving their medication. The hub offers a next-day turnaround service for all orders sent before 1 pm.

“Sometimes patients can’t wait until the next day for their medicines for various reasons, and that is absolutely fine.

“The pharmacy teams can easily recall the prescriptions, regardless of what stage of the process the prescription is currently in. However, by simply ordering their prescriptions enough in advance, patients can really help to take the pressure off our teams by giving us a chance to make use of the hub,” shares Chris.

Benefits of implementing hub and spoke model

They both say since introducing a hub and spoke model they have seen a number of benefits and they would recommend this model of dispensing to other pharmacies.

“On average, we feel we have freed up four hours per day for the pharmacist. Some days it is more, some days it is less but that’s the experience of our pharmacists working in a range of small and large volume branches.

“Errors have decreased due to the barcode technology and in terms of stock, the key has been less wastage. Instead of 39 pharmacies all having their own stockpile, we pull drug usage data to inform our stock holding and this results in a lower chance of wastage,” says Chris

“Going forward as we grow in the number of pharmacies, we can scale our hub operation as needed. It is a crucial resource to help our pharmacies cope with an ever-increasing workload, with services like Pharmacy First now taking centre stage,” he adds.

More For You

Skill mix and independent prescribing: The essential ingredients for pharmacy’s future

L-R: Nicola Stockmann, Robert Townsend, Atul Patel, and Amerjit Singh

Skill mix and independent prescribing – Key to driving pharmacy forward

“The workforce is your greatest asset,” said Nicola Stockmann, president of the Association of Pharmacy Technicians UK (APTUK).

Speaking at the recent Pharmacy Business Conference, she emphasised that investing in the entire pharmacy team, including pharmacy technicians and assistants, is essential for sustainable growth.

Keep ReadingShow less
How community pharmacies can safely and profitably deliver high-quality NHS and private services

L-R: Baba Akomolafe, Rachna Chhatralia, Patricia Tigenoah-Ojo, and Raj Matharu

How community pharmacies are optimising services for a sustainable future

“Community pharmacy has come to a point where we have to change ourselves,” said Raj Matharu, CEO at Community Pharmacy South East London, and Superintendent Pharmacist of Westchem Pharmacy, as he opened a panel discussion at the recent Pharmacy Business Conference.

The 'Optimising Service Opportunities' session centred on how community pharmacies can safely and profitably deliver high-quality NHS and private services, while ensuring an excellent patient experience.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less